DRUG
Price
$43.27
Change
+$4.47 (+11.52%)
Updated
Sep 3 closing price
Capitalization
278.36M
IVA
Price
$5.77
Change
+$0.51 (+9.70%)
Updated
Sep 3 closing price
Capitalization
733.09M
21 days until earnings call
Interact to see
Advertisement

DRUG vs IVA

Header iconDRUG vs IVA Comparison
Open Charts DRUG vs IVABanner chart's image
Bright Minds Biosciences
Price$43.27
Change+$4.47 (+11.52%)
Volume$35.15K
Capitalization278.36M
Inventiva SA
Price$5.77
Change+$0.51 (+9.70%)
Volume$86.57K
Capitalization733.09M
DRUG vs IVA Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. IVA commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a StrongBuy and IVA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (DRUG: $38.80 vs. IVA: $5.26)
Brand notoriety: DRUG and IVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 74% vs. IVA: 468%
Market capitalization -- DRUG: $278.36M vs. IVA: $733.09M
DRUG [@Biotechnology] is valued at $278.36M. IVA’s [@Biotechnology] market capitalization is $733.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileIVA’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • IVA’s FA Score: 0 green, 5 red.
According to our system of comparison, IVA is a better buy in the long-term than DRUG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 3 TA indicator(s) are bullish while IVA’s TA Score has 6 bullish TA indicator(s).

  • DRUG’s TA Score: 3 bullish, 5 bearish.
  • IVA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IVA is a better buy in the short-term than DRUG.

Price Growth

DRUG (@Biotechnology) experienced а -13.33% price change this week, while IVA (@Biotechnology) price change was +14.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

IVA is expected to report earnings on Sep 25, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVA($733M) has a higher market cap than DRUG($278M). IVA YTD gains are higher at: 145.794 vs. DRUG (7.718).
DRUGIVADRUG / IVA
Capitalization278M733M38%
EBITDA-8.94MN/A-
Gain YTD7.718145.7945%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash51.4MN/A-
Total Debt141KN/A-
TECHNICAL ANALYSIS
Technical Analysis
DRUGIVA
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 21 days ago
85%
Bullish Trend 7 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HOOCX28.19-0.15
-0.53%
Hartford Schroders US Small Cap Opps C
PNRAX57.54-0.33
-0.57%
Putnam Research A
MITGX33.45-0.24
-0.71%
MFS Massachusetts Investors Tr R1
RTSAX40.21-0.32
-0.79%
Russell Inv Tax-Managed US Mid&Sm Cap A
BRZKX13.06-0.12
-0.91%
BlackRock Sust Aware Adg Intl Eq K

DRUG and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRUG has been loosely correlated with WVE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DRUG jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRUG
1D Price
Change %
DRUG100%
-0.22%
WVE - DRUG
44%
Loosely correlated
+0.21%
IVA - DRUG
44%
Loosely correlated
-15.02%
PHMMF - DRUG
44%
Loosely correlated
N/A
TVGN - DRUG
32%
Poorly correlated
-2.20%
ATYR - DRUG
31%
Poorly correlated
+5.02%
More

IVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVA has been loosely correlated with DRUG. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then DRUG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
-15.02%
DRUG - IVA
43%
Loosely correlated
-0.22%
TVGN - IVA
36%
Loosely correlated
-2.20%
KRRO - IVA
35%
Loosely correlated
-3.79%
WVE - IVA
32%
Poorly correlated
+0.21%
IVF - IVA
27%
Poorly correlated
-3.74%
More